Randall Bateman

U.S. Sen. Roy Blunt, R-Mo., visited the Medical Campus this week to meet with physicians who treat patients with Alzheimer’s disease, and patients and caregivers who live with the debilitating disease every day. Blunt, pictured with physician-scientist Randall J. Bateman, chairs a subcommittee that oversees funding for medical research.

The National Institutes of Health (NIH) has boosted funding for the first large-scale clinical trial aimed at identifying drugs to stop or slow Alzheimer’s disease in people who are destined to get it. The trial is led by Randall Bateman, MD.

U.S. Sen. Roy Blunt (left) and Francis S. Collins, director of the National Institutes of Health, visited the School of Medicine this week to talk to researchers, administrators and entrepreneurs about scientific research and the need to boost and sustain federal funding for it.

Four WUSTL faculty members were recognized for their accomplishments during the Faculty Achievement Awards ceremony Dec. 7 in Simon Hall. (From left) David M. Holtzman, MD, and Randall J. Bateman, MD, received the Chancellor’s Award for Innovation and Entrepreneurship Award from Chancellor Mark S. Wrighton. James V. Wertsch, PhD, and Richard H. Gelberman, MD, received the Arthur Holly Compton Faculty Achievement Award and the Carl and Gerty Cori Faculty Achievement Award, respectively.

Finding ways to diagnose and treat Alzheimer’s disease has frustrated scientists and clinicians for decades. But now the battle has reached a potentially significant milestone: the launch of the first clinical trials to test whether giving new drug treatments before dementia can prevent Alzheimer’s. Shown are School of Medicine MDs and Alzheimer’s researchers Randall Bateman (left) and John C. Morris.

Scientists at the School of Medicine have measured a significant and potentially pivotal difference between the brains of patients with an inherited form of Alzheimer’s disease and healthy family members who do not carry the mutation. Randall Bateman, MD, is the study’s senior author.

Randall Bateman, MD, has been named the Charles F. and Joanne Knight Distinguished Professor in Neurology at Washington University School of Medicine in St. Louis.

Randall Bateman, MD, had no intention of becoming a doctor when he enrolled as an undergraduate at Washington University in St. Louis. As a faculty member at the School of Medicine since 2006, Bateman now focuses his research on Alzheimer’s disease.

Three faculty members of the School of Medicine will be honored by the Academy of Science of St. Louis: Randall Bateman, M. Carolyn Baum and Alan L. Schwartz.